CytoSorbents to Report Q2 2019 Operating and Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall St choppy as megacap losses offset chip gains before Fed decision
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise about 2% as Yemen fighting stokes supply fears
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| Cytosorbents Corporation (NASDAQ: CTSO) | Delayed: 5.30 +0.45 (9.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.85 | 52 Week High | $7.48 | |||
| Open | $4.97 | 52 Week Low | $3.11 | |||
| Day High | $5.42 | P/E | N/A | |||
| Day Low | $4.86 | EPS | $-0.03 | |||
| Volume | 12,605 | |||||
